Molina Healthcare Inc. (NYSE:MOH) shares saw strong trading volume on Tuesday . 1,082,156 shares traded hands during trading, an increase of 0% from the previous session’s volume of 1,078,166 shares.The stock last traded at $57.59 and had previously closed at $57.58.

Several analysts have issued reports on the company. Cantor Fitzgerald restated a “hold” rating and set a $55.00 price objective on shares of Molina Healthcare in a research note on Friday, July 29th. Jefferies Group restated a “buy” rating and set a $63.00 price objective (down previously from $66.00) on shares of Molina Healthcare in a research note on Thursday, July 28th. Leerink Swann restated a “buy” rating on shares of Molina Healthcare in a research note on Thursday, July 28th. Zacks Investment Research cut Molina Healthcare from a “hold” rating to a “sell” rating in a research note on Thursday, July 21st. Finally, Credit Suisse Group AG restated a “hold” rating on shares of Molina Healthcare in a research note on Tuesday, June 28th. Three investment analysts have rated the stock with a sell rating, six have issued a hold rating and five have given a buy rating to the company. The stock presently has a consensus rating of “Hold” and a consensus price target of $65.75.

The firm has a market cap of $3.20 billion and a PE ratio of 24.41. The company’s 50 day moving average is $53.89 and its 200-day moving average is $55.86.

Molina Healthcare (NYSE:MOH) last released its earnings results on Wednesday, July 27th. The company reported $0.67 earnings per share for the quarter, topping analysts’ consensus estimates of $0.49 by $0.18. During the same period last year, the business earned $0.72 earnings per share. The firm had revenue of $4.36 billion for the quarter, compared to analyst estimates of $4.35 billion. The firm’s quarterly revenue was up 23.7% compared to the same quarter last year. On average, equities analysts anticipate that Molina Healthcare Inc. will post $2.72 earnings per share for the current year.

In related news, insider Joseph W. Cpa White sold 6,676 shares of Molina Healthcare stock in a transaction dated Thursday, August 4th. The stock was sold at an average price of $58.48, for a total transaction of $390,412.48. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Also, Director Steven J. Orlando sold 2,500 shares of Molina Healthcare stock in a transaction dated Monday, August 8th. The stock was sold at an average price of $58.82, for a total value of $147,050.00. The disclosure for this sale can be found here.

A number of large investors have recently added to or reduced their stakes in MOH. Trexquant Investment LP purchased a new stake in Molina Healthcare during the fourth quarter worth $1,463,000. Redwood Investments LLC increased its stake in Molina Healthcare by 62.4% in the fourth quarter. Redwood Investments LLC now owns 25,416 shares of the company’s stock worth $1,528,000 after buying an additional 9,763 shares during the last quarter. Mutual of America Capital Management LLC increased its stake in Molina Healthcare by 3.3% in the fourth quarter. Mutual of America Capital Management LLC now owns 28,039 shares of the company’s stock worth $1,686,000 after buying an additional 887 shares during the last quarter. Matarin Capital Management LLC bought a new stake in Molina Healthcare during the fourth quarter worth $4,484,000. Finally, Calvert Investment Management Inc. bought a new stake in Molina Healthcare during the fourth quarter worth $4,577,000.

Molina Healthcare, Inc offers Medicaid-related solutions for low-income families and individuals, and assists government agencies in their administration of the Medicaid program. The Company operates through three segments: Health Plans, Molina Medicaid Solutions and Other. Its Health Plans segment consists of health plans in approximately 10 states and the Commonwealth of Puerto Rico, and its direct delivery business.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.